Actinium Pharmaceuticals Total Liabilities

Actinium Pharmaceuticals (ATNM) currently reports a total liabilities of $9.9M as of June 2026. That compares with $44M in the prior-year period — down 77.6% year over year. Use the charts on this page to explore Actinium Pharmaceuticals's total liabilities history and peer comparisons.

Actinium Pharmaceuticals's total liabilities decreased from $44M to $9.9M — a 77.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Actinium Pharmaceuticals reported $9.9M in total liabilities as of June 2026. That compares with $44M in the prior-year period — down 77.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $9.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Actinium Pharmaceuticals, and consider following ATNM for alerts when major investors trade the stock.

Actinium Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $9.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATNM with unrelated industries.